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Abstract NHERF, a 55 kDa PDZ-containing protein, binds
receptors and ion transporters to mediate signal transduction at
the plasma membrane. Recombinant NHERF demonstrated an
apparent size of 150 kDa on gel filtration, which could be
reduced to approximately 55 kDa by protein denaturing agents,
consistent with the formation of NHERF dimers. Biosensor
studies established the time- and concentration-dependent
dimerization of NHERF. Overlays of recombinant NHERF
fragments suggested that NHERF dimerization was principally
mediated by the N-terminal PDZ-I domain. In PS120 cells,
reversible protein phosphorylation modulated NHERF dimeriza-
tion and suggested a role for NHERF dimers in hormonal
signaling. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The Na/H exchanger isoform 3 (NHE3) located in the
rabbit renal proximal tubules mediates the reabsorption of
sodium, HCO33 and water in response to cyclic AMP
(cAMP) and parathyroid hormone. Isolated apical mem-
branes demonstrate NHE3 activity that is inhibited by PKA
[1]. This led to the isolation of a 45 kDa protein, termed Na/
H exchanger regulatory factor or NHERF, from detergent-
solubilized brush border membranes, that was essential for
PKA inhibition of NHE3 reconstituted in liposomes [2]. The
rabbit NHERF cDNA encodes a 55 kDa protein [3] that
reconstitutes cAMP inhibition of Na/H exchange in
NHE3-expressing PS120 cells. Recent studies suggest that
NHERF links NHE3 to ezrin, a PKA-anchoring protein, to
facilitate the cAMP-mediated phosphorylation of NHE3 and
inhibition of Na/H exchange [4]. NHERF is itself phos-
phorylated in mammalian cells, most likely by GRK6A, a
member of the G-protein-coupled receptor kinase family [5],
but the function of this covalent modi¢cation remains un-
known.
NHERF distribution between cytosol and membranes is
modulated by serum factors [6]. As NHERF targets are pri-
marily membrane proteins [7], the role of cytosolic NHERF is
currently unclear. Estimates of NHERF in the mammalian
kidney exceed those of the known NHERF targets. This
also suggests that the majority of NHERF is not bound to
target proteins and the physiological signals may dictate
NHERF’s availability to its membrane targets. We noted a
di¡erence in the apparent molecular size of NHERF in the
renal cytosol compared to NHERF extracted from brush bor-
der membranes. Analysis of recombinant NHERF using sev-
eral techniques shows that it exists as a dimer both in vitro
and in vivo. Our studies suggest that NHERF dimerization
requires the ¢rst PDZ (PSD-95/Discs large/ZO-1) domain, the
binding site for many NHERF targets. Finally, NHERF
dimers were dissociated by protein phosphorylation. This sug-
gests that assembly and disassembly of NHERF dimers rep-
resents a mechanism for hormonal control of plasma mem-
brane receptors and transporters.
2. Materials and methods
Rabbit NHERF cDNA inserted into pET30A (Stratagene) was ex-
pressed in Escherichia coli as a hexahistidine-tagged fusion protein
and puri¢ed on Ni-Sepharose as previously described [8]. The N-ter-
minal PDZ domain (amino acids 11^101) was excised as a SacI frag-
ment and ligated into pET30A digested with BSSH-SacI. The SacI^
XhoI fragment of the rabbit cDNA encoding a C-terminal fragment of
NHERF (amino acids 152^358) was ligated into pET30A digested
with the same enzyme. Both NHERF fragments were expressed in
E. coli and puri¢ed on Ni-Sepharose. The NHERF cDNAs were
ligated into the following mammalian expression vectors ^ NHERF
cDNA transferred from pET30a into pcDNA3 (provided by Chris
Yun, Johns Hopkins University), pBK-CMV (provided by Randy
Hall, Emory University) and pFlag-CMV-2 (provided by Maria-Mag-
dalena Georgescu, Rockefeller University) ^ that yielded hexahisti-
dine-tagged, HA-tagged and FLAG-tagged proteins, respectively.
All NHERF constructs were transfected into PS120-NHE3V cells us-
ing lipofectamine as described [4]. Immunoprecipitation and Western
immunoblotting with anti-hexahistidine (KPL), anti-HA.11 (Babco)
and anti-FLAG M2 (Sigma) were carried out essentially as previously
described [4].
2.1. Gel ¢ltration of NHERF
Recombinant rabbit His-NHERF was subjected to gel ¢ltration on
Superose 6 FPLC in 50 mM Tris^HCl, pH 7.5 containing 0.1 mM
EDTA, 15 mM L-mercaptoethanol and 150 mM NaCl at a £ow rate
of 0.5 ml/min. NHERF, denatured in 6 M guanidine hydrochloride
(GuHCl) at 25‡C for 30 min, was also subjected to gel ¢ltration in
50 mM Tris^HCl, pH 7.5 containing 0.1 mM EDTA, 15 mM L-mer-
captoethanol and 6 M GuHCl. Molecular weight protein markers
(vitamin B12, ovalbumin, Q-globulin and thyroglobulin) were obtained
from Bio-Rad. Protein elution was monitored as absorbance at 280 nm
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using a bu¡er blank. Western immunoblotting with anti-NHERF was
also used to monitor NHERF elution.
2.2. Biosensor analysis of NHERF binding
Puri¢ed recombinant His-NHERF (100 ng) was coupled to dex-
tran-coated cuvettes using EDC/NHS as recommended by the manu-
facturer (IAsys Application Note 2.1). The cuvette was washed exten-
sively with 50 mM Tris^HCl, pH 7.5 containing 0.1 mM EDTA,
15 mM L-mercaptoethanol and 150 mM NaCl to remove unbound
protein. Soluble His-NHERF was added in the same bu¡er with rapid
stirring and protein^protein binding monitored as a time-dependent
change in polarization of the laser in Arc-secs.
2.3. Overlays with NHERF
Recombinant full-length His-NHERF and its fragments were sub-
jected to SDS^PAGE on 10% (w/v) acrylamide gels. The proteins were
electrophoretically transferred to PVDF membranes, blocked with 1%
non-fat milk and incubated with 1 WM phosphorylated NHERF, 32P-
labelled at a serine in the linker region using PKA and detected by
autoradiography or unphosphorylated His-NHERF monitored by
Western blotting with anti-S-tag monoclonal antibody [9].
3. Results and discussion
NHERF (Mr 45 000 on SDS^PAGE) obtained from deter-
gent-solubilized rabbit brush border membranes migrated on
gel ¢ltration with an apparent Mr of approximately 60 000 [3].
In contrast, the 100 000Ug supernatant of rabbit kidney cor-
tex contained NHERF (Mr 55 000 on SDS^PAGE) that mi-
grated with an apparent Mr of 150 000 (data not shown). To
examine the basis for this size di¡erence, we fractionated
highly puri¢ed recombinant His-NHERF by Superose 6
FPLC (Fig. 1, solid line). Bulk of the protein migrated as a
peak of Mr 150 000 with less than a third showing an apparent
Mr 50 000 consistent with monomeric His-NHERF. Incuba-
tion of His-NHERF in 6 M GuHCl (Fig. 1, dotted line)
reduced its apparent molecular size. The denatured His-
NHERF migrated as a broad peak ranging from Mr 75 000
to 45 000. This demonstrated that soluble His-NHERF
formed oligomeric complexes that could be disrupted by
GuHCl.
To further analyze the oligomerization of NHERF, we uti-
lized a biosensor (Fig. 2). Soluble His-NHERF bound to His-
NHERF immobilized on the dextran surface of the biosensor
cuvette in a time- and concentration-dependent manner. The
data were most consistent with the formation of NHERF
homodimers. NHERF was immobilized at low protein con-
centration and washed extensively to favor the coupling of
monomeric NHERF to the biosensor cuvette. However, as
discussed above, the soluble ligand was largely dimeric His-
NHERF. Thus, NHERF^NHERF association seen with the
biosensor represents an exchange of NHERF from the soluble
dimers to the NHERF monomers immobilized in the cuvette.
High concentrations of soluble His-NHERF showed non-spe-
ci¢c, hydrophobic binding to the dextran surface. Thus, stan-
dard algorithms for analyzing protein^protein interactions
could not be applied and the a⁄nity for NHERF dimerization
could not be accurately determined. However, we estimated
from these studies that that NHERF self-associates with low
a⁄nity with Kd between 1 and 10 WM.
An overlay assay [9] was used to de¢ne the regions of
NHERF that mediate its dimerization. Full-length NHERF
and the N-terminal PDZ-I domain (amino acids 11^101)
bound with low a⁄nity (requiring between 10 and 20 Wg of
protein), to both phosphorylated (Fig. 3) and unphosphory-
Fig. 1. Gel exclusion chromatography of recombinant NHERF. Pu-
ri¢ed recombinant rabbit His-NHERF was subjected to gel ¢ltration
on Superose 6 FPLC (solid line) as described in Section 2. Apparent
Mr values of two major protein peaks were calculated using stan-
dard molecular weight protein markers and are indicated with ar-
rows. Recombinant NHERF, denatured with 6 M GuHCl, was also
fractionated following in bu¡er containing 6 M GuHCl (dotted
line).
Fig. 2. Biosensor analysis of NHERF^NHERF binding. Recombi-
nant His-NHERF was immobilized to a dextran-coated cuvette as
described in Section 2. Following extensive washing, increasing
amounts of soluble His-NHERF were added. NHERF binding was
observed as time- and concentration-dependent increase in rotation
of the polarized laser in Arc-secs.
Fig. 3. Overlays with recombinant NHERF. Full-length His-
NHERF (amino acids 1^358), the fragments termed PDZ-I (amino
acids 11^101), and PDZ-II (amino acids 152^358) were subjected to
SDS^PAGE. The proteins were electrophoretically transferred to
PVDF membrane, renatured in bu¡er lacking SDS and incubated
with 32P-labelled NHERF, whose binding was visualized by autora-
diography.
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lated His-NHERF (data not shown). No NHERF was bound
to the C-terminal PDZ-II domain (amino acids 152^385). In
other experiments, His-tagged PDZ-I bound the full-length
NHERF and PDZ-I while PDZ-II failed to bind full-length
NHERF, PDZ-I or PDZ-II (data not shown). These results
contrasted sharply with a recent report [10], in which recombi-
nant rat GST-NHERF (termed EBP50 or ezrin binding pro-
tein of apparent Mr 50 000) bound GST-NHERF in an over-
lay (Kd 100 nM). Moreover, both rat NHERF PDZ domains
bound each other, with PDZ-I showing a preference for PDZ-
1 and PDZ-II preferring PDZ-II. The basis for these very
di¡erent results is still unclear but as indicated above,
NHERF isolated from rabbit renal apical membranes con-
tains PDZ-II and C-terminus that is essential for NHE3 reg-
ulation and is phosphorylated at C-terminal serines by PKA
[4]. This suggests that the 45 kDa rabbit NHERF was pro-
teolyzed at its N-terminus. Inability of the truncated NHERF
to form higher molecular weight complexes supports our sug-
gestion that N-terminal sequences within PDZ-I are required
for NHERF dimerization. Chemical cross-linking of rat
NHERF primarily yielded dimers [10], consistent with the
biosensor data discussed above.
To demonstrate NHERF dimerization in vivo, we expressed
mouse NHERF with two distinct tags, HA and FLAG, in
PS120 cells. Immunoprecipitation with either anti-HA or
anti-FLAG monoclonal antibodies followed by immunoblot-
ting with the converse antibody established the association of
HA-NHERF to FLAG-NHERF in vivo (Fig. 4A). To over-
come the ine⁄ciency of co-immunoprecipitations, we also ex-
pressed mouse NHERF as a hexahistidine-tagged protein in
PS120 cells. This enhanced the extraction of NHERF and
NHERF-bound proteins from cell extracts. A⁄nity isolation
of His-NHERF on Ni-Sepharose also removed a signi¢cant
portion of HA-NHERF co-expressed in these cells (Fig. 4A).
HA-NHERF did not bind to Ni-Sepharose when it was ex-
pressed in cells by itself (data not shown), establishing that the
binding of HA-NHERF to the Ni-a⁄nity matrix required its
dimerization with His-NHERF.
Next, we analyzed potential cellular mechanisms that regu-
late NHERF dimerization. Treatment of PS120 cells with 10%
serum, 0.1 mM cell-permeable cAMP analogs, the calcium
ionophore, A23187, and phorbol esters for periods ranging
from 15 min to 3 h had no e¡ect on NHERF dimerization.
However, 1 WM okadaic acid, which inhibits the two major
protein serine/threonine phosphatases, PP1 and PP2A, re-
sulted in signi¢cant reduction in NHERF dimers in the
PS120 cell extracts. The process was slow with only 17 þ 1%
reduction in NHERF dimerization after 15 min exposure to
okadaic acid. NHERF dimerization was, however, greatly re-
duced (65 þ 7%) when cells were treated for 3 h with okadaic
acid. These e¡ects were not due to the cytotoxicity of okadaic
acid and could be reversed following the removal of the phos-
phatase inhibitor. Okadaic acid also did not reduce the ex-
pression of His-NHERF. If anything, equal or greater
amounts of His-NHERF were extracted by Ni-Sepharose
from okadaic acid-treated PS120 cells. This provides the ¢rst
evidence that protein phosphorylation regulates NHERF di-
merization in cells. It is unclear at this time whether phos-
phorylation of NHERF itself or its cellular targets modulates
NHERF dimerization in PS120 cells. The apparent lack of
di¡erence in binding of phosphorylated and unphosphory-
lated NHERF to immobilized NHERF and NHERF peptides
in the overlay assay would argue against the phosphorylation
of NHERF as the primary mechanism of dissociating
NHERF dimers. On the other hand, insensitivity of the over-
lays may miss small changes in the a⁄nity of the phosphor-
ylated and unphosphorylated NHERF dimers. Clearly, fur-
ther work is required to elucidate the mechanisms that
regulate NHERF complexes in mammalian cells and in turn
control its physiological functions.
The NHERF PDZ-I binds L2-adrenergic receptor [11], P2Y
and PDGF receptors [9], cystic ¢brosis transmembrane regu-
lator [12], and GRK6A protein kinase [5]. Dimerization of
Fig. 4. NHERF dimerization in PS120 cells. A shows the immuno-
precipitations (IP) with anti-HA (top left) and anti-FLAG (top
right) from PS120 cells expressing HA- and FLAG-NHERF. West-
ern immunoblotting (WB) showed that HA-NHERF bound FLAG-
NHERF in PS120 cell extracts. Nickel chelate chromatography was
used to isolate His-NHERF from PS120 extracts. Immunoblotting
with anti-HA antibody established the presence of HA-NHERF in
eluates from the Ni-column (bottom left). Immunoblotting of anti-
HA immunoprecipitates with an anti-hexahistidine antibody also es-
tablished the association of His-NHERF with HA-NHERF (bottom
right). B shows that Ni-Sepharose adsorbed His-NHERF from ex-
tracts of control (top left) and PS120 cells treated for 3 h with 1 WM
okadaic acid (top right), readily recognized by immunoblotting with
an anti-NHERF antibody. Association of HA-NHERF with His-
NHERF was seen in control cells (bottom left) but was signi¢cantly
reduced in cells treated with okadaic acid (bottom right).
FEBS 24559 25-1-01
S. Shenolikar et al./FEBS Letters 489 (2001) 233^236 235
NHERF via PDZ-I is likely to preclude its binding to these
targets and perhaps represents an inactive or latent pool of
NHERF. On the other hand, ligand binding to L2-adrenergic
receptors recruits NHERF [11] and has been implicated in the
desensitization of hormone signals [13]. In this context,
NHERF dimerization may facilitate the clustering of recep-
tors at clathrin-coated pits and promote their internalization
and degradation [13]. Signaling by the PDGF receptor tyro-
sine kinase (PDGF-R), another NHERF target, mandates
PDGF-R dimerization. Here, dimerization of NHERF and
its homologue, NHERF2, facilitates PDGF signaling [14], ac-
counting for the identi¢cation of NHERF2 as TKA-1, an
activator of PDGF-R [9].
PDZ-I is dispensable for the assembly of NHE3/NHERF/
ezrin complex that mediates cAMP inhibition of Na/H ex-
change in PS120 cells [4] and NHERF dimerization via PDZ-I
may not prevent NHE3 regulation. However, association of
L2-adrenergic receptor to NHERF PDZ-I prevents NHE3 in-
hibition by cAMP [11]. While the precise mechanism remains
unclear, NHERF dimerization via PDZ-1 could also preclude
its interaction with NHE3 and the dissociation of NHERF
dimers by protein phosphorylation may be necessary for its
function as an NHE3 regulator. In conclusion, we have shown
that NHERF dimers exist in vivo and in vitro and comprise a
pool of NHERF whose dissociation is regulated by reversible
protein phosphorylation. Future studies will address the phys-
iological importance of NHERF dimerization and de¢ne the
phosphorylation events that regulate NHERF dimerization
and function in mammalian cells.
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